期刊文献+

抗肝肠钙粘连蛋白单克隆抗体对肝癌细胞生物学行为的影响

Targeting liver-intestine cadherin with a monoclonal antibody blocks the growth of human hepatocellular carcinoma cell lines
原文传递
导出
摘要 目的观察抗肝肠钙粘连蛋白(CDHl7)单克隆抗体Lie5对肝癌细胞生物学行为的影响。方法Westernblot和实时定量聚合酶链反应(PCR)检测细胞株MHCC97H、MHCC97L、PLC/PRF/5及MIHA中CDHl7的表达。噻唑蓝(MTr)比色法、细胞划痕法、Transwell法及平板克隆法检测Lie5对肝癌细胞生物学行为的影响。结某CDHl7仅在细胞株MHCC97H、MHCC97L中表达,Lic5可结合肝癌细胞表面的CDHl7,并抑制CDHl7表达。Lic550mg/L组、100mg/L组、小鼠IgG组4d细胞增殖抑制率在MHCC97H为26.1%、43.6%、6.4%,MHCC97L为26.O%、40.7%、7.7%;Lic5100mg/L组、小鼠IgG组、磷酸盐缓冲液(PBS)组48h细胞迁移抑制率在MHCC97H为36.7%、8.4%、5.6%,MHCC97L为42.3%、10.2%、7.4%(P〈0.05);穿膜细胞数在MHCC97H为(39.20±9.56)、(106.50±7.56)、(96.60±3.02)个,MHCC97L为(26.00±8.61)、(86.00±10.26)、(90.40±12.04)(P〈0.05);克隆形成数在MHCC97H为(59.30±11.68)、(141.70±19.40)、(150.30±14.64)。MHCC97L为(57.20±10.21)、(132.50±9.07)、(121.70±11.93)(P〈0.01)。Lic5对PLC/PRFl5及MIHA细胞的生物学行为无明显影响。结论单克隆抗体Lie5能够下调肝癌细胞CDH17表达,抑制肝癌细胞的增殖、迁移、侵袭和克隆形成能力。 Objective To investigate the effect of monoclonal antibody against liver-intestine cadherin (CDH17) on the cell proliferation, migration, invasion and colony formation of hepatocellular carcinoma cell lines. Methods Hepatocellular carcinoma cell lines MHCC97H, MHCC97L, PLC/PRF/5 and MIHA were examined for CDH17 expression by Western blotting and quantitative real-time polymerase chain reaction (PCR). The combination capacity between hepatocellular carcinoma cell lines and monoclonal antibody Lic5 was detected by the way of immunofluorescence staining. The cell lines were treated with LicS, PBS and mouse IgG respectively. Methyl thiazol tetrazolium (MTT) assay, wound healing assay, Transwell invasion assay and colony formation assay were used to study the changes in cell proliferation, migration, invasion and colony formation of hepatocellular carcinoma cell lines. Results High expression level of CDH17 was detected in MHCC97H and MHCC97L cell lines. CDH17 protein level was down-regulated but there was no significant effect on CDH17 mRNA after treatment with Lic5 in MHCC97H and MHCC97L. Cellular growth rate of MHCC97H in Lic5 (50 mg/L), Lic5 (100 mg/L) and mouse IgG groups was decreased by 26. 1% , 43.6% and 6. 4% , and by 26. 0% , 40. 7% and 7. 7% in MHCC97L on the 4th day respectively (P 〈0. 05). The inhibition rate of cell migration at 48 h was 36.7%, 8. 4% and 5.6% in Lic5 (100 mg/L), mouse IgG and PBS groups in MHCC97H, and 42. 3% , 10. 2% and 7. 4% in MHCC97L respectively ( P 〈 0. 05 ). The number of invasion cells was ( 39. 20 ± 9. 56 ), (106. 50 ±7.56) and (96. 60±13.02) in MHCC97H, and (26.00 ±8.61), (86.00±10.26) and (90.40 ± 12. 04) in MHCC97L in Lic5 (50 mg/L), Lic5 ( 100 mg/L) and mouse IgG groups, respectively (P 〈 0. 05 ). The number of colony formation was ( 59.30 ± 11.68 ), ( 141.70 ± 19.40 ) and (150.30±14.64) inMHCC97H, and (57.20±10.21), (132.50 ±9.07) and (121.70±11.93) in MHCC97L in L
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第8期1295-1298,共4页 Chinese Journal of Experimental Surgery
关键词 肝肠钙粘连蛋白 单克隆抗体 肝细胞 Liver-intestine cadherin Monoclonal antibody Carcinoma, hepatocellular
  • 相关文献

参考文献3

二级参考文献9

  • 1王曙光,韩本立,陈意生,彭志明,贺光友.胆管癌转移途径的病理学研究[J].中华外科杂志,1996,34(6):352-354. 被引量:38
  • 2王曙光,韩本立,段恒春,陈意生,彭志明.肝外胆管癌细胞系的建立[J].中华实验外科杂志,1997,14(2):67-68. 被引量:66
  • 3Shih SC,Stutman O.Cell cycle-dependent tumor necrosis factor apoptosis.Cancer Res,1996,56:1591-1598. 被引量:1
  • 4Nagata S,Golstein P.The Fas death factor.Science,1995,267:1449-1456. 被引量:1
  • 5Rensing-Ehl A,Frei K,Flury R Local Fas APO-1 (CD95) ligandmediated tumor cell killing in vivo.Eur J Immunol,1995,25:2253-2258. 被引量:1
  • 6Liu HF,Liu WW,Fang DC Clinical significance of Fas antigen expression in gastric carcinoma.Zhonghua Binglixue Zazhi,1998,27:228. 被引量:1
  • 7Golstein P.Controlling cell death.Science,1997,275:1081-1084. 被引量:1
  • 8Itoh N,Tsujimoto Y,Nagata S.Effect of bcl-2 on Fas antigen-mediated cell death.J lmmunol,1993,151:621-627. 被引量:1
  • 9Lacronique V,Mignon A,Fabre M Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.Nat Med,1996,2:80-86. 被引量:1

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部